Search results for “Xylenesulfonate” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 354 patents, we discovered top 93 key players by total patent application. Procter & Gamble Co., Novartis AG, Akzo Nobel NV are dominant in this area. They take 24.86% of the total patent filing.
Procter & Gamble Co.
Ohio, United States
Patent: 46
Novartis AG
Basel-Stadt, Switzerland
Patent: 24
Akzo Nobel NV
Noord-Holland, Netherlands
Patent: 18
Henkel AG & Co. KGaA
Nordrhein-Westfalen, Germany
Patent: 18
Novapharm Research Australia Pty Ltd
New South Wales, Australia
Patent: 15
Sanofi-Aventis Deutschland GmbH
Hessen, Germany
Patent: 11
Colgate-Palmolive Co.
New York, United States
Patent: 9
Kao Corp.
Tokyo-to, Japan
Patent: 8
Shell Internationale Research Maatschappij BV
Zuid-Holland, Netherlands
Patent: 8
Intra-Cellular Therapies, Inc.
New York, United States
Patent: 7
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 37 patents applied in the last 5 years. We discover 16 most active companies in this area. The fast-growing Intra-Cellular Therapies, Inc., Qurient Co., Ltd., CRT Pioneer Fund LP take 48.65% of patent filing during this period.
Intra-Cellular Therapies, Inc.
New York, United States
Patent: 7
Qurient Co., Ltd.
Gyeonggi-do, South Korea
Patent: 6
CRT Pioneer Fund LP
United Kingdom
Patent: 5
Sandoz AG
Switzerland
Patent: 3
Crystal Pharmaceutical (Suzhou) Co., Ltd
Jiangsu Sheng, China
Patent: 2
NATCO Pharma Ltd.
Andhra Pradesh, India
Patent: 2
Pharmacostech Co., Ltd.
South Korea
Patent: 1
Xinjiang Fufeng Biotechnologies Co. Ltd.
Xinjiang Uygur Zizhiqu, China
Patent: 1
Niitaka Co., Ltd.
Osaka-fu, Japan
Patent: 1
Teva Pharmaceuticals International GmbH
Switzerland
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 37 patents in last 5 years, we discover 15 new entrants. Intra-Cellular Therapies, Inc., Qurient Co., Ltd., CRT Pioneer Fund LP are the most active new entrants in this area.
Intra-Cellular Therapies, Inc.
New York, United States
Patent: 7
Qurient Co., Ltd.
Gyeonggi-do, South Korea
Patent: 6
CRT Pioneer Fund LP
United Kingdom
Patent: 5
Sandoz AG
Switzerland
Patent: 3
Crystal Pharmaceutical (Suzhou) Co., Ltd
Jiangsu Sheng, China
Patent: 2
NATCO Pharma Ltd.
Andhra Pradesh, India
Patent: 2
Pharmacostech Co., Ltd.
South Korea
Patent: 1
Xinjiang Fufeng Biotechnologies Co. Ltd.
Xinjiang Uygur Zizhiqu, China
Patent: 1
Niitaka Co., Ltd.
Osaka-fu, Japan
Patent: 1
Landa Labs (2012) Ltd.
Israel
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 9 patents, we discovered top 6 universities and scientific research institutions by total patent application. The University of North Carolina at Chapel Hill, Council of Scientific & Industrial Research, North Carolina State University are dominant in this area. They take 55.56% of the total patent filing.
The University of North Carolina at Chapel Hill
North Carolina, United States
Patent: 3
Council of Scientific & Industrial Research
Delhi, India
Patent: 1
North Carolina State University
North Carolina, United States
Patent: 1
Petru Maior University of Targu Mures
Romania
Patent: 1
Northeast Petroleum University
Heilongjiang Sheng, China
Patent: 1
Zhongshan Torch Polytechnic
Guangdong Sheng, China
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: